|
|
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | “When I came to Florida,” James Sapirstein says, “I was leaving New Jersey because of tax reasons.” That was 2018. Timing is everything, they say. Sapirstein’s relocation placed him ahead of a broadening and intensifying migration trend – including he believes, a new biotechnology settlement. This is not news to readers – Miami alone seems perennially in the headlines. “Economics drives investors,” Sapirstein says, and Sapirstein is committed spearheading “a new kind of biotech cluster." | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Trends In Mid-Size Scale Up Strategies | Video | LOTTE Biologics | A development leader highlights supply‑chain resilience, cost‑efficient large‑scale manufacturing, proven tech‑transfer success, and long‑term commitment to supporting clients through production strategies. |
|
|
| Raising The Bar For Large‑Molecule Development | Video | Cytovance Biologics | How a seasoned development and manufacturing team blends technical depth, reliability, and flexible support to advance large‑molecule programs amid shifting timelines, costs, and regulatory demands. |
|
|
|
|
| Getting Your Proof Of Clonality Right For Regulators | Article | Abzena | Regulators require clear, verifiable proof that production cell lines originate from a single progenitor cell, supported by imaging, documentation, and data integrity to ensure product consistency and safety. |
|
|
|
|
|
|
| Outsourced Pharma Capabilities Update | This online event series connects biopharma companies with CDMOs to explore capabilities across biologics production, HPAPI manufacturing, and drug–device combination development. Through concise presentations, CDMOs showcase expertise in development, scale-up, containment, and GMP manufacturing. Attendees gain insights into technologies, regulatory expectations, and partnership models, while engaging directly with providers to evaluate outsourcing options and identify the best-fit partners for advancing and commercializing complex therapies. Click to learn more. |
|
|
|
An Integrated, Verified PFS System For Vaccines | West Pharmaceutical Services, Inc. | A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on drug-specific performance. |
|
|
Mammalian Protein Development And Manufacturing | Avid Bioservices | With proven expertise in process development, optimization, and CGMP manufacturing, Avid offers end-to-end CDMO solutions backed by flexible capacity designed to scale with program needs. |
|
|
|
|
Biologics Development | Recipharm Advanced Bio | We offer industry‑leading biologics development services, supporting global clients across all clinical phases and regulatory pathways, including process and formulation development. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
